RecruitingPhase 4NCT06263452

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress


Sponsor

University of North Carolina, Chapel Hill

Enrollment

120 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to map the neural and molecular mechanisms underlying psychological stress-induced changes in inflammation which could reveal new targets for intervention to reduce the risk of cardiovascular disease.


Eligibility

Min Age: 18 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called Propranolol for people with cardiovascular disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPropranolol

Tablet encapsulated to visually look identical to the placebo.

DRUGPlacebo

Encapsulated sugar pill to visually look identical to the experimental condition.


Locations(1)

Social Neuroscience and Health Laboratory

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06263452


Related Trials